6 completed, 1 terminated, 1 unknown. 8 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 6, Terminated 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Desogestrel: new trials by email Literature Review of Desogestrel trials Research Report on Desogestrel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo Desogestrel Oral Tablet - Endometrioma | Phase 2 / Phase 3 | Completed | Department of Medical Services Ministry of Public Health of Thailand | 20 | 2021-06-01 | 2022-10-31 |
| Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome Desogestrel - Congenital Central Hypoventilation Syndrome | Phase 2 | Terminated | Children's Hospital Los Angeles | 1 | 2012-02-01 | 2023-11-18 |
| A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women desogestrel/ethinyl estradiol and ethinyl estradiol, desogestrel/ethinyl estradiol - Hemostasis, Oral Contraceptive | Phase 2 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 293 | 2011-10-31 | 2021-12-06 |
| Assessment of Desogestrel in Ondine Syndrome desogestrel - Ondine Syndrome | Phase 2 / Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 6 | 2011-04-01 | 2013-11-14 |
| A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women 91-day Levonorgestrel Oral Contraceptive, 28-day Levonorgestrel Oral Contraceptive, 28-day Desogestrel Oral Contraceptive - Hemostasis, Oral Contraceptive | Phase 2 | Completed | Teva Women's Health | 265 | 2010-11-01 | 2015-03-13 |
| Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's Health Marvelon - Women With PMS | Phase 2 | Unknown | Tehran University of Medical Sciences | 61 | 2010-09-01 | 2010-12-08 |
| Antagonist/Letrozole in Poor Responders letrozole, oral contraceptive (Marvelone), GnRH agonist (buserelin) - Ovarian Stimulation | Phase 1 / Phase 2 | Completed | Yazd Research & Clinical Center for Infertility | 120 | 2008-06-01 | 2013-12-23 |
| Feasibility Study Into the Contraceptive Effect of Estetrol estetrol, estetrol and desogestrel, estetrol and progesterone - Healthy | Phase 2 | Completed | Pantarhei Bioscience | 52 | 2007-11-01 | 2012-05-07 |
Thrombosis (2) · Congenital central hypoventilation syndrome (1) · Endometriosis (1) · Sleep Apnea, Central (1)
Assistance Publique - Hôpitaux de Paris (1) · Children's Hospital Los Angeles (1) · Department of Medical Services Ministry of Public Health of Thailand (1) · Pantarhei Bioscience (1) · Tehran University of Medical Sciences (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1) · Teva Women's Health (1) · Yazd Research & Clinical Center for Infertility (1)
Iran (2) · Italy (2) · United States (2) · France (1) · Germany (1) · Israel (1) · Netherlands (1) · Spain (1) · Thailand (1)
H. Coelingh Bennink, MD, PhD (1) · Iris Perez, MD (1) · Ratchadaporn Roekyindee, MD (1)